EMEA-001369-PIP01-12
Submitted by Anonymous (not verified) on 8 May 2026 - 9:12
EMEA-001369-PIP01-12
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 8 May 2026 - 9:08
Human medicines European public assessment report (EPAR): Nintedanib Viatris, nintedanib, Date of authorisation: 22/08/2025, Revision: 1, Status: Authorised
EMEA-002051-PIP02-16
Submitted by Anonymous (not verified) on 8 May 2026 - 8:55
EMEA-002051-PIP02-16
Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Revision: 1, Status: Authorised
Submitted by Anonymous (not verified) on 8 May 2026 - 8:49
Human medicines European public assessment report (EPAR): Teizeild, teplizumab, Date of authorisation: 08/01/2026, Revision: 1, Status: Authorised
Revamp of marketing authorisation assessment templates
Submitted by Anonymous (not verified) on 8 May 2026 - 8:30
Revamp of marketing authorisation assessment templates
PSUSA/00002357/202508
Submitted by Anonymous (not verified) on 8 May 2026 - 7:57
PSUSA/00002357/202508
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 11, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 16:55
Human medicines European public assessment report (EPAR): Mysildecard, sildenafil, Date of authorisation: 15/09/2016, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 16:45
Human medicines European public assessment report (EPAR): Entecavir Viatris (previously Entecavir Mylan), entecavir, Date of authorisation: 18/09/2017, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 16:40
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Duloxetine Viatris (previously Duloxetine Mylan), duloxetine, Date of authorisation: 19/06/2015, Revision: 23, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2026 - 16:30
Human medicines European public assessment report (EPAR): Duloxetine Viatris (previously Duloxetine Mylan), duloxetine, Date of authorisation: 19/06/2015, Revision: 23, Status: Authorised